One more Chinese COVID-19 vaccine ready for phase-3 clinical trials
A COVID-19 vaccine candidate developed by the Institute of Microbiology under the Chinese Academy of Sciences has shown to be safe in early-stage trials, suggesting potential for further clinical tests.The results of phase-1 and phase-2 trials support the safety and immunogenicity of this recombinan

